Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder [Phase 2]
A Phase 2 safety and efficacy study of vilazodone in patients with Major depressive disorder, including exploration of genetic markers assoc…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder [Phase 2, Phase 3]
Pioglitazone is being studied as an adjunctive treatment for moderate to severe major depressive disorder in Phase 2 and Phase 3 trials. The…
-
CLINICAL_TRIALS research · 2012-05-09Clinical Trial Update: Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial update evaluating an escitalopram combination therapy for adults with major depressive disorder; current status is …
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: The WORKER Study: Escitalopram and Telephone-based Cognitive Behaviour Therapy (CBT) for Depressed Working People [NA]
A completed clinical trial evaluating escitalopram in combination with telephone-based CBT for depressed working adults.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women [Phase 3]
Phase 3 study evaluating Desvenlafaxine succinate sustained release (DVS SR) versus placebo in peri- and postmenopausal women with depressio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Vocal Acoustic Biomarkers in Depression
Completed clinical trial evaluating vocal acoustic biomarkers in major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Tailored Internet-delivered Cognitive Behaviour Therapy in Primary Care [NA]
This clinical trial update reports on a tailored internet-delivered cognitive behaviour therapy program tested in primary care for depressio…
-
CLINICAL_TRIALS research · 2012-05-04Clinical Trial Update: Study of Ketamine as an Antidepressant in Major Depressive Disorder [Phase 1, Phase 2]
Clinical trial update on ketamine as an antidepressant for Major Depressive Disorder, spanning Phase 1 and Phase 2 studies; current status i…
-
FDA approval · 2012-05-03FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Computerized Information-Processing Bias Retraining in Depressed Adolescents [Phase 2]
Phase 2 trial evaluating a computerized information-processing bias retraining program for adolescents with major depressive disorder has co…
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Cognitive Behavioral Therapy, Self-Efficacy, and Depression in Persons With Chronic Pain
The document reports a completed clinical trial evaluating cognitive behavioral therapy and its impact on depression and self-efficacy in in…
-
FDA approval · 2012-05-03FDA Approved: ESCITALOPRAM — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's original application for escitalopram oxalate, a generic version of the antidepressant escitalopram.
-
FDA approval · 2012-05-02FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride (Vertical Pharmaceuticals, LLC) to update the product labeling und…
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients [NA]
A completed clinical study evaluated a stress reduction intervention to improve treatment outcomes for depressed minority patients with Majo…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Are Two Antidepressants a Good Initial Treatment for Depression? [Phase 4]
Phase 4 trial evaluating whether starting treatment with two antidepressants is a good initial approach for major depressive disorder and re…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Treatment of Depression Following Multiple Brain Tests [Phase 4]
A Phase 4 clinical trial evaluating a treatment for major depressive disorder and persistent depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression [Phase 4]
Phase 4 trial update reporting termination of sequential tranylcypromine-based regimens for refractory depression (tranylcypromine alone, wi…
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Effectiveness of Pramipexole for Treatment-Resistant Depression [Phase 4]
Phase 4 clinical trial update assessing the effectiveness of pramipexole for treatment-resistant depression.
-
FDA approval · 2012-04-25FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s supplemental application for the generic antidepressant citalopram.
-
FDA approval · 2012-04-25FDA Approved: CITALOPRAM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals LLC's supplemental application for citalopram, a generic antidepressant, under the ANDA program.
-
FDA approval · 2012-04-25FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram hydrobromide by Aurobindo Pharma Limited. This constitutes a supplemental approval fo…
-
FDA approval · 2012-04-25FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Citalopram from Mylan Pharmaceuticals Inc. The action relates to the generic product, approv…
-
CLINICAL_TRIALS trial_result · 2012-04-25Clinical Trial Update: Depression Prevention Program for Adolescents [NA]
Completed clinical trial update on a depression prevention program for adolescents.
-
CLINICAL_TRIALS withdrawal · 2012-04-24Clinical Trial Update: Expanding and Testing VA Collaborative Care Models for Depression [NA]
A clinical trial evaluating VA collaborative care models for major depressive disorder and post-traumatic stress disorder has been withdrawn…
-
FDA approval · 2012-04-23FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for Bupropion HCl sustained-release (Actavis), finalizing changes to the approved generic product.